Glenmark
Pharma to opt for ADRs/GDRs
New Delhi: Glenmark Pharma plans to raise funds
through either American or Global Depository Receipts
(ADRs/GDRs) in order to increase its capital base. The
company's shareholders have also approved enhancement
of its borrowing limits up to Rs1,000 crore, the company
has informed the Bombay Stock Exchange.
The
company has already received shareholders' nod for issue
of ADRs, GDRs and allotment of bonds, debentures. The
shareholders have also approved the issue of warrants
or any instruments convertible into equity shares whether
optionally or otherwise.
Back to News Review
index page
Granules
India raises $8.65 mn through GDR issue
Hyderabad: Granules India Ltd has informed the
stock exchanges that following the approval of its shareholders
at the extraordinary general meeting held on September
25 last year, to issue up to $15-million global depository
receipts (GDRs), the issue accordingly opened on January
13 and closed on January 19.
The company said it has received an amount of $86,50,316
as subscription monies.
Further, the company said its board meeting held on January
20 has issued and allotted 37,61,007 equity shares of
Rs10 each in favour of the Depository.
Back
to News Review index page
Suryajyoti
Spinning board okays preferential offer
Hyderabad: The board of directors of Suryajyoti
Spinning Mills Ltd, the Hyderabad-based yarn producer,
at its meeting on Friday has approved a preferential offer
to promoters and non-promoters and also considered term
loans for the proposed expansion.
The board has approved preferential issue of 14-lakh warrants
convertible into 14-lakh equity shares of face value of
Rs10 each at a price not exceeding Rs29 on preferential
basis to promoters and key management persons.
The board has also decided to forfeit 3,81,925 equity
shares.
Back
to News Review index page
|